retatrutide clinical trials results produces up to 30.3% weight loss in Phase 3 trial Retatrutide, an experimental drug currently

However, the role of endogenous GLP-1 in the attenuation of reward-oriented behavior, and the essential domains of the mesolimbic system mediating these beneficial effects, are largely unknown

The rise of GLP-1 weight-loss drugs is shifting consumer habits

Whether you're active or just starting your journey, this patch backs your progress every step of the way

Understand the key differences between oral and injectable GLP-1 medications, including bioavailabil

A side-by-side editorial look at Compounded Semaglutide vs Wegovy: mechanism, FDA status, real-world cost, and the GLP-1 pathway genetics most providers don'

Cardiologists also had a greater tendency than the other specialties to give the International Non-proprietary Name (INN) of new GLP-1s, rather than the brand name.